Filing Details

Accession Number:
0000950117-10-000388
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-29 13:00:00
Reporting Period:
2010-03-25
Filing Date:
2010-03-29
Accepted Time:
2010-03-29 14:38:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
50710 Javelin Pharmaceuticals Inc JAV Pharmaceutical Preparations (2834) 880471759
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1311634 B Daniel Carr C/O Javelin Pharmaceuticals, Inc.
125 Cambridgepark Drive
Cambridge MA 02140
President And Cmo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-03-25 5,307 $1.07 160,601 No 4 M Direct
Common Stock Disposition 2010-03-25 4,700 $1.35 155,901 No 4 S Direct
Common Stock Acquisiton 2010-03-26 767 $1.07 156,668 No 4 M Direct
Common Stock Disposition 2010-03-26 700 $1.35 155,968 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2010-03-25 5,307 $0.00 5,307 $1.07
Common Stock Stock Option Disposition 2010-03-26 767 $0.00 767 $1.07
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
90,593 2019-01-23 No 4 M Direct
89,826 2019-01-23 No 4 M Direct
Footnotes
  1. Includes (i) 31,246 shares of common stock, (ii) 5,000 shares of common stock purchased pursuant to the Issuer's Employee Stock Purchase Plan and (iii) 119,048 Deferred Stock Units (DSUs) granted on May 1, 2009.
  2. Granted under the Issuer's Amended and Restated 2005 Stock Incentive Plan.
  3. Vesting in three equal annual installments beginning after the first year.